dopamine beta-hydroxylase
| GO Term | Evidence Code | PMID |
|---|---|---|
| blood vessel remodeling | ||
| blood vessel remodeling | ||
| response to amphetamine | ||
| response to amphetamine | ||
| leukocyte mediated immunity |
| GO Term | Evidence Code | PMID |
|---|---|---|
| secretory granule lumen | ||
| secretory granule lumen | ||
| chromaffin granule membrane | ||
| neuronal cell body | ||
| terminal bouton |
| GO Term | Evidence Code | PMID |
|---|---|---|
| dopamine beta-monooxygenase activity | ||
| dopamine beta-monooxygenase activity | ||
| dopamine beta-monooxygenase activity | ||
| dopamine beta-monooxygenase activity | ||
| dopamine beta-monooxygenase activity |
| Location | References |
|---|---|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025